The Asthma Treatment Market Size was valued at USD 26.7 billion in 2023, and is expected to reach USD 42.13 billion by 2032, and grow at a CAGR of 5.2% over the forecast period 2024-2032.
The increase in the cases of asthma, and the chronic condition are rising the growth of the Asthma Treatment Market. This rising patient population need the development of innovative and effective treatment options, which rises the demand for advanced therapies. The COVID-19 pandemic increases the number of asthma patients, which rises the need for improvement in the management strategies. The advancement in the technology rises the growth of the market. For instance, wearable devices, remote monitoring, and data analytics are enabling personalized treatment plans, enhancing patient compliance, and creating new market opportunities. The increasing focus on patient-centric care, with rising healthcare expenditures and the rise in public awareness about the asthma, is rises the growth of the Asthma Treatment Market.
The environmental factors, such as air pollution and allergens, also rises the asthma disease, which increase the need for effective management solutions. The increase in the aging population, with its associated increased risk of chronic diseases including asthma. Government initiatives about the public health and disease prevention, with increasing healthcare accessibility in developing regions, are also drives the growth of the market. Also, the increase in research into asthma pathophysiology and genetics is increases the development of novel therapeutic targets and treatment modalities, further enhance the growth of the market. The rise in biologics and targeted therapies, with the increasing adoption of combination therapies, is rises the market growth opportunities. The rise in focus on patient education and self-management programs is improved asthma control and reduced exacerbation rates.
Get Free Sample Copy of Report: https://www.snsinsider.com/sample-request/3387
KEY MARKET SEGMENTATION
By Treatment
- Long-Term Control Medications
- Quick-Relief Medications
By Route of Administration
- Injectable
- Inhaled
- Oral
By Distribution Channel
- Online Pharmacies
- Retail Pharmacies & Drug Stores
- Hospital Pharmacies
Segment Analysis
By Treatment, Long-Term Control Medications segment dominated theAsthma Treatment Market with more than 92.8% of market share in 2023 due to asthma’s chronic nature, these medications, including well-known brands like Advair and Symbicort, are essential for managing symptoms.
By Route of Administration, Inhaled segment dominated theAsthma Treatment Market with high market share in 2023, due to its direct delivery of medication to the airways, minimizing side effects, driven by established products like Pulmicort and Qvar.
By Distribution Channel, Hospital Pharmacies segment dominated theAsthma Treatment Market with high market share in 2023, due to the specialized care required for many asthma therapeutics. These medications are administrated by trained medical professionals and strict adherence to treatment guidelines, ensuring optimal symptom control and patient safety.
Key Players
- AstraZeneca
- Teva Pharmaceutical Industries Ltd.
- Merck & Co. Inc.
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline PLC
- Sanofi
- Mylan N.V.
- Genentech Inc. (F. Hoffmann-La Roche Ltd)
- Regeneron
- Novartis AG
Recent Developments
August 2023: Areteia Therapeutics unveiled positive results from its Phase 2 EXHALE-1 study, demonstrating a reduction in blood eosinophil count, a potential breakthrough for asthma treatment.
July 2023: Teva Pharmaceuticals expanded its biosimilar portfolio through a partnership with Alvotech, targeting the US market.
March 2023: AstraZeneca’s Tezspire gained approval for self-administration via a prefilled pen, improving convenience for severe asthma patients aged 12 and older.
Regional Analysis
The North America dominated the growth of the Asthma Treatment Market with highest market share in 2023. This dominance is due a well-established healthcare infrastructure, high number of cases of asthma, and the presence of major pharmaceutical players in this region. The increase in the air pollution levels, an aging population, and a rise demand for effective asthma medications also rises the growth of the market in this region.
The Asia-Pacific region is growing in this market. This growth is due to several factors, such as, healthcare reforms, rise in geriatric population, and increase in the awareness about lung diseases. The government initiatives to improve the treatment quality and rise in research & development activities. Leading Chinese companies are actively innovating new therapeutic options, for the drug delivery systems. This region has innovative collaborations and partnerships between industry stakeholders, academic institutions, and patient advocacy groups.
Key Takeaways
- The report clarifies that the increasing burden of asthma on patient quality of life is a key catalyst for market expansion, necessitating innovative treatment options.
- Understanding the impact of the COVID-19 pandemic on the asthma patient population is crucial. The report underscores the need for improved management strategies in the post-pandemic era.
- The report acknowledges the pivotal role of technological advancements, such as wearable devices and data analytics, in personalizing asthma care and driving market growth.
- The report underscores the influence of environmental factors, aging populations, and government initiatives on market growth. These elements contribute to a rising demand for asthma management solutions.
- A clear understanding of the evolving treatment landscape, including the rise of biologics, targeted therapies, and combination treatments, is essential for market players to capitalize on emerging opportunities.
Make Enquiry About Asthma Treatment Market Report: https://www.snsinsider.com/enquiry/3387
Table of Content
Chapter 1 Introduction
Chapter 2 Research Methodology
Chapter 3 Asthma Treatment Market Dynamics
Chapter 4 Impact Analysis (COVID-19, Ukraine- Russia war, Ongoing Recession on Major Economies)
Chapter 5 Value Chain Analysis
Chapter 6 Porter’s 5 forces model
Chapter 7 PEST Analysis
Chapter 8 Asthma Treatment Market Segmentation, By Treatment
Chapter 9 Asthma Treatment Market Segmentation, By Route of Administration
Chapter 10 Asthma Treatment Market Segmentation, By Distribution Channel
Chapter 11 Asthma Treatment Market – Regional Analysis
Chapter 12 Company profile
Chapter 13 Competitive Landscape
Chapter 14 Use Case and Best Practices
Chapter 15 Conclusion
Access This Full Report with Charts And Graphs @ https://www.snsinsider.com/reports/asthma-treatment-market-3387
Other Related Report
Demineralized Bone Matrix (DBM) Market Size
Blood Pressure Monitors Market Size
About US:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Contact Us:
Akash Anand – Head of Business Development & Strategy,
info@snsinsider.com,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),
Website: https://www.snsinsider.com/